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Abstract Medication dosing errors are frequent in neonatal
wards. In an Iranian neonatal ward, a 7.5 months study was
designed in three periods to compare the effect of
Computerized Physician Order Entry (CPOE) without and
with decision support functionalities in reducing non-
intercepted medication dosing errors in antibiotics and
anticonvulsants. Before intervention (Period 1), error rate
was 53%, which did not significantly change after the
implementation of CPOE without decision support (Period
2). However, errors were significantly reduced to 34% after
that the decision support was added to the CPOE (Period 3;
P<0.001). Dose errors were more often intercepted than
frequency errors. Over-dose was the most frequent type of
medication errors and curtailed-interval was the least.
Transcription errors did not reduce after the CPOE
implementation. Physicians ignored alerts when they could
not understand why they appeared. A suggestion is to add
explanations about these reasons to increase physicians’
compliance with the system’s recommendations.
Keywords Medical order entry systems . Decision support
systems, clinical .Medication errors . Infant, newborn .
Patient safety . Iran
Background
Medication errors can prolong hospital stay and increase
costs and mortality [1]. Children are at higher risk from
medication errors because of weight-based dosing, lower
tolerance to a dosing error, and limitations in communicat-
ing with health providers to explain the adverse event [2].
The problem becomes even more significant in neonatal
wards where the patients are more susceptible to medication
errors because of their unique issues [3, 4]. Potential
Adverse Drug Events (ADE) occur three times more often
in newborns than in adults. Most of the medication errors
happen at the prescribing stage, and the most common type
is dose error [5]. Antibiotics are among the most frequently
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involved drug groups [5, 6]. Severe adverse events have
been reported due to dose miscalculation of the prescribed
anticonvulsants [7].
Many studies in adults and paediatrics have reported that
computerized physician order entry (CPOE) has the ability
to reduce different types of medication errors [8–12].
However, there are studies that have identified the negative
effects of CPOE in facilitating certain types of medication
errors or increasing mortality rate [13–17]. These results are
not necessarily contradictory but they are difficult to
compare because of different design and implementation
methods [18].
Despite its importance, few studies have evaluated the
effect of CPOE on prescription dosing errors in a neonatal
ward or Neonatal Intensive Care Unit (NICU). Gard et al.
[19] reported elimination of the self-reported dose calcula-
tion errors of antibiotics in a NICU following the
implementation of a computer-generated antimicrobial dose
calculator. Cordero et al. [20] found that gentamicin dose
calculation error among very low birth-weight neonates was
eradicated after the implementation of CPOE. These studies
show that CPOE has been effective at reducing dose
medication errors in neonatal patients.
Despite the benefits, implementation of CPOE is
challenging for different reasons, including physicians’
resistance [21] and high costs [22]. Physicians’ compliance
with the system’s recommendations is low and a majority of
the warnings are ignored [23]. Despite the great effort on
the national level, only about 23% of the children hospitals
and less than 15% of the general hospitals in the USA, the
leading country in CPOE, have implemented CPOE [24,
25]. The success rate is even less in many European
countries that have implemented CPOE [24]. Implementa-
tion of these systems in middle- or low-income countries is
more challenging because of financial as well as human
resource constraints [26]. In 2007 a CPOE project was
started in the Islamic Republic of Iran. Iran is a low-middle-
income country in the Middle East, with almost 70 million
inhabitants [27].
In the cooperation strategic plan, Iran has promised the
World Health Organization to extend the use of health
information technology and evidence-based decision-
making in the health sector [28]. Previous studies on
medication errors and ADEs in Iran have revealed that
preventable medication errors frequently happen. In one
study that was conducted in a tertiary-care teaching hospital
in Tehran, nearly 60% of the adverse events were
preventable. The most probable causes were inappropriate
doses, intervals, and choice of the prescribed drugs [29]. In
another study, medication-related problems in Iran were
responsible for 11.5% of admissions and were mostly
preventable. Dose-related problems were among the most
frequent causes [30]. The results of these studies demon-
strate that the Iranian healthcare system may benefit from
the implementation of CPOE with dose decision support
functionalities, especially in those clinical settings that are
heavily dependent on accurate dose calculation like the
neonatal ward. However, the effects should be investigated.
The aim of this study was to investigate the effect of
physician order entry and decision support system on
reducing medication dosing errors of antibiotics and
anticonvulsants in an Iranian neonatal ward.
Methods
Setting
Hamadan is a province in North West of Iran, with almost
1,700,000 inhabitants. Besat is a 400-bed tertiary-care
referral teaching hospital in the capital city of Hamadan,
providing different clinical services. Besat’s neonatal ward
is a 17-bed clinical ward that includes two NICU beds.
Inclusion criteria and study population
Neonates, who received antibiotics for infectious diseases
or anticonvulsants for seizure, were included in the study.
For the included patients, all administered antibiotics and
anticonvulsants were included. A prescribed medication
that was continued during a day and had led to adminis-
tration was defined as a medication-day. Therefore, even if
the prescribed medication was repeated in several renewed
orders on the same day, it was considered as one
medication-day. When the dose and frequency of the
prescribed medication was correct in all orders of the same
day, it was considered as one correct medication-day
otherwise it was counted as one erroneous medication-day.
System description
Clinical information system
Sayan-HIS (Sayan Rayan Co. Ltd., Hamadan, Iran) is a
commercial patient-centred hospital information system
(HIS) that is used in all 15 university-affiliated hospitals
in Hamadan. The clinical information system of Sayan-HIS
includes functionalities for order entry. When the physi-
cian’s order is entered into the computer, the prescription
system delivers the requested order for medications, lab
tests, and imaging to their relevant target hospital sections
at the appropriate time. The user interface of the prescrip-
tion system remained intact during the study period.
The system constrains the selection of drugs and their
possible pharmaceutical forms (vial, ampoule, tablet, etc.)
through drop-down lists and pre-constructed orders. A
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minimum and maximum dose reminder is also available.
This alert is to some extent useful for adults but not for
neonates whose dose may vary up to tenfold for the same
drug because of the weight-based dose calculation.
Clinical Decision Support System
Before CPOE implementation, a knowledge-base was
created by using the local guidelines of best practice based
on the paediatric reference books that were approved by the
National Board of Paediatrics in Iran [31, 32]. The
knowledge-base was completed for all routine antibiotics
and anticonvulsants, based on the patient’s clinical diagno-
sis, age, weight, gestational age, and glomerular filtration
rate (GFR). Three neonatal sub-specialists reviewed the
knowledge-base and approved its compliance with the
original guidelines. A computer function was developed
to calculate GFR for neonates based on the patient’s
creatinine clearance, body surface area (BSA), age, and
gestational age. A paediatric nephrologist tested the
functionality of the GFR calculator, reviewed its compli-
ance with the references [33, 34], and approved it. All
prescribers were informed that they had to comply with the
mentioned guidelines while setting the dose and frequency
of medications.
At the time of order entry, a rule based CDSS
examined the dose and frequency of each prescribed
medication, based on the mentioned references (Fig. 1).
It requested the prescription system to provide detailed
information required for retrieving relevant dose and
frequency ranges from the knowledge-base. According to
the calculated GFR, the renal function evaluator compo-
nent determined whether the dose should be adjusted, and
to what extent. Based on all above information, the
clinical inference unit calculated the patient specific
appropriate dose and frequency, and compared the results
with the prescribed dose and frequency. If the prescribed
dose or frequency was not within the normal range, the
DSS informed the prescriber about the appropriate dose
and/or frequency by demonstrating a warning message
that asked for correction. The prescriber was however,
allowed to ignore it. If the prescriber accepted the
correction, the order was updated based on the DSS
recommendation. Prescriber’s response to the warning,
was recorded in an error registration table. Detailed
information on decision flow is shown in Fig. 2.
The design of the CDSS was based on a previous
study where the physicians believed that, since these
advanced technologies are not affordable everywhere in
Iran, interns and residents should be able to set
appropriate doses without computer support, but could
receive feedback if the error was going to harm the
patient [26].
Definition of medication errors
In this study we investigated prescription and transcription
errors, but not the administration errors. Among different
prescription parameters, dose and frequency were selected
because they are the most common source of prescription
errors in the neonatal setting [5, 6].
Over- or under-dosages and curtailed or prolonged
intervals were considered as medication errors. Those
medication errors that were prevented before they reached
patients were categorized as intercepted and those that
reached patients were categorized as non-intercepted
medication errors.
A prescription error was defined as a medication that
was prescribed with an erroneous dose or frequency by
the physician. Prescription errors occur at the time of
selecting the reference dose, calculating the patient-
specific dose, and registering dose in the order book. A
transcription error was defined as a medication that was
registered with an erroneous dose in the paper-based
nursing report while the prescribed order was correct.
The other types of dose transcription errors such as
delayed or omitted doses were not included in this
study.
Study periods and their characteristics
This study was designed to cover three consecutive
2.5-month intervals consisting of Period 1—Before inter-
vention; Period 2—Physician order entry; and Period 3—
Physician order entry and CDSS providing dose and
frequency warnings. This study was conducted between
May 2007 and December 2007 (Table 1).
Period 1—Before intervention
In the neonatal ward, residents were responsible for
calculating the appropriate dose and frequency of the
prescribed medications and registering them in the paper-
based order sheets. In Period 1, nurses transcribed
prescription orders to the computer and physicians did
not interact with the computer system (Fig. 3). They also
transcribed prescribed medications to the paper-based
nursing Cardex that was used for drug preparation. After
the administration, the delivered dose and administration
time was registered in the paper-based administration
chart.
During this period, two of the authors (A.K. and A.A.)
conducted group and private training sessions for the
residents to teach them how to use the prescription system.
Residents could also obtain access to a demo version of the
system for further training.
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Period 2—Physician order entry
In Period 2, physician order entry was introduced as a
separate period to evaluate the role of physicians’ data entry
without the assistance of the computer-generated warnings
in reducing or increasing dose and/or frequency medication
errors. At the beginning of this period, paediatric residents
took responsibility for entering prescription orders into the
computer (Table 1). However, when a resident had
completed the electronic registration of an order, a nurse
checked and electronically countersigned the order to verify
it (Fig. 3). In this period, transcription of paper-based orders
to the computer was eliminated but transcription to the
cardex and paper-based nursing reports were continued
(Asterisks in Fig. 3).
To evaluate the non-intercepted medication errors in
Period 1 and 2, patients’ order books were reviewed to
complete missing information on weight, height, gestational
age, and the clinical diagnosis in the HIS, and medication
errors were assessed retrospectively (Table 1).
Period 3—Physician order entry and CDSS providing
warnings
In Period 3, residents continued to enter prescriptions into the
computer (Table 1). In addition, warning messages became
functional and informed physicians following a dose or
frequency medication error (Fig. 3). If the prescriber ignored
a warning, the next warning would appear when one of the
decision criteria (diagnosis, age, weight, GFR, etc.) was
changed in the renewed order or a new erroneous dose and/
or frequency was set for that medication.
In this period, when a resident complained about a
warning that was perceived by him /her as being inappro-
priate, A.K. asked him/her to explain how did he/she
calculate the dose and frequency for that medication and
Fig. 1 Schematic view of the CDSS architecture, and its interactions with the prescription system
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took notes. Then he reviewed the system’s calculation
method and compared the two approaches far from the
resident. The aim was to explore the reasons for the ignored
warnings and the possible causes of medication errors
without influencing the prescriber. At the end of Period 3
the results of these investigations were categorized into
main causes of errors (presented in the result section).
Statistics
A two-tailed Chi-square test was performed to find statisti-
cally significant differences in the proportion of medication
errors between Period 1 and 2, and Period 2 and 3 [35]. We
also employed Chi-square for trend (Mantel extension) to
investigate whether there was a linear incremental or
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decreasing trend in the proportion of the non-intercepted
medication errors from Period 1 to Period 3 [36]. The change
in error rate between the study periods was calculated as
r ¼ Initial period error rate Final period error ratej j.
Medication-day (a prescribed medication that is contin-
ued during a day and has led to administration) was used as
the unit of analysis. Medication-days account for both the
number of concurrent medications used for one patient and
the duration that a medication is continued. The risk of harm/
benefit per each medication-day can be considered as one
standard unit. Therefore, in this error calculation method, the
number of concurrent patients, medications, and the length
of stay cannot adversely affect medication errors.
Ethical considerations
The National Ethical Committee at the Ministry of Health
and Medical Education in Iran issued ethical permission for
this study in 2005. Residents and nurses were informed of
their rights to withdraw at any time. All physicians and
nurses volunteered to take part in the study.
Results
Baseline characteristics
During the study period, 248 patients met the inclusion
criteria and were included in this study (Table 2). There
were no significant difference in sex, and gestational age
in the three periods. The average age on admission was
about 3 to 6 days. The median length of hospital stay of
the included patients was about 7 days and their
prescribed medications were continued between 5 and
6 days.
In Period 2, 69 orders belonging to eight patients who
met the inclusion criteria, but the orders were entered by the
nurses, were excluded from the study. The reason was that
the aim of this period was to investigate the effect of
physicians’ order entry.
Non-intercepted medication errors
Most of the non-intercepted medication errors occurred
during the prescription stage (Table 3). The rate of
transcription errors was not significantly different in the
three periods.
Before intervention (Period 1), the rate of non-
intercepted medication errors was about 53% (Table 3).
Introducing CPOE without the CDSS functionality in
Period 2 did not significantly decrease or increase non-
intercepted medication errors. However, after the intro-
duction of the dose and frequency CDSS in Period 3, the
rate of non-intercepted medication errors was reduced to
34% (19% reduction compared to Period 1; P<0.001;
Table 3).
Dose and frequency errors
Dividing non-intercepted medication errors into dose and
frequency errors showed a 3% non-significant reduction in
dose errors between Period 1 and 2, while there was no
significant difference between frequency errors of these two
periods. Both dose and frequency errors had significant
reduction between Period 2 and 3 (Table 4). However, dose
errors were more often intercepted than frequency errors
(19% reduction for dose errors and 5% for frequency errors
compared to Period 1).
Sub-types of dose and frequency errors
After dividing dose errors into over-dose and under-dose,
and frequency errors into prolonged and curtailed intervals,
apart from the curtailed interval, all other error types
showed a highly significant linear reduction from Period 1
to Period 3 (P<0.001; Fig. 4). Over-dose was the most
Table 1 CPOE implementation periods at the neonatal ward of the Besat hospital
Period 1
May–Jul 2007
Period 2
Jul–Oct 2007
Period 3
Oct–Dec 2007
Intervention No intervention POE POE + CDSS
CDSS functionality N/A N/A Warnings
Order entry Nurses Physicians Physicians
Documentation HWP E-Prints E-Prints
Transcription to Computer + Cardex + PBNR Cardex + PBNR Cardex + PBNR
Review process EO + EMAC + PBO + PBNR EO + EMAC + PBNR EO + EMAC + PBNR + ERT
POE physician order entry, CDSS clinical decision support system, HWP hand-written prescription, E-Prints electronic prints (of prescriptions),
PBNR paper-based nursing report, PBO paper-based orders, EO electronic orders, EMAC electronic medication administration chart, ERT error
registration table, N/A not available
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frequent, and curtailed-interval the least frequent error type
in Period 1 and Period 2. After the introduction of CDSS
functionality, over-dose dropped by 40% in Period 3 (11%
reduction from Period 1 to Period 3). However, curtailed
interval was not significantly reduced. Under-dose dropped
by 60% (8% reduction) and prolonged interval by 24% (5%
reduction).
While only 21% (20/96) of the patients in Period 1 and
18% (15/83) in Period 2 were error-free, the rate was
increased to 35% in Period 3 (28/79; P=0.02).
In Period 3, Physicians complied with 53 warnings while
ignored 108 (33% compliance rate).
Main causes of errors
Based on the personal discussions with prescribers
to find specific reasons for the errors and ignored
warnings, five main causes were identified: medication-
diagnosis mismatch, dose adjustment difficulties, ignor-
ing the new age-group, selecting a “neighbouring cell”,
and miscalculations.
Medication-diagnosis mismatch
Sometimes antibiotics were prescribed with an inappropri-
ate diagnosis. For example, meningitis dose was prescribed
for a less severe infectious disease.
Dose adjustment difficulties
Residents seemed to have problems in correctly interpreting
the GFR and detecting renal impairment. The situation
became more complicated when the prescriber had to
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recalculate the dosage based on every new plasma
creatinine result.
Ignoring the new age group
Based on the mentioned dose table [31], the frequency and/
or dose should have changed for most of the antibiotics
when the age of the hospitalized patient changed from the
seventh to the eighth day of life. Interviews and personal
discussions revealed that prescribers had rarely applied the
necessary change.
Selecting a “neighbouring cell”
In order to select the appropriate dose and frequency in the
guideline table [31], residents had to find the appropriate
age and weight group for the selected medication based on
the diagnosis. Sometimes they calculated the dose and
frequency based on a wrong “neighbouring cell”, probably
because of visual mistakes, or by choosing the inappropri-
ate diagnosis, age or weight group.
Miscalculations
Miscalculations occurred frequently. During the shifts, three
residents were responsible for all paediatric patients in the
paediatric intensive care unit, the neonatal ward, the two
general paediatric wards, and the emergency ward of the
hospital. They were busy, under tension and stress, and could
easily make mistakes while calculating dose and frequency.
Discussion
Period 1
In this study, the error rate in Period 1 was much higher
than in many similar studies in western countries [10, 37].
There are a number of possible reasons that may explain
this circumstance. For example, unlike many western
hospitals, in Iran nurses prepare the ready-to-administer
doses without any supervision or involvement of hospital
pharmacists which increases the risk of medication errors
[26, 38, 39].
The absence of a clinical pharmacist during the clinical
rounds to detect the potential adverse events and to remind the
prescribers of their medical faults at the time of prescription is
another problem in this setting. The result of two studies in the
US and UK demonstrates a 66% to 80% reduction of
medication errors following the active involvement of a
senior clinical pharmacist in the clinical rounds [40, 41].
Table 2 Distribution and characteristics of the included patients,
orders, and medications in the three periods
Period 1 Period 2 Period 3
Patientsa 96 83 79
Male/female 47/49 43/40 42/37
Median age on admission (days) 5 3 6
Median gestational age (weeks) 38 38 38
Orders 1,248 1,080 878
Medications in the orders 2,728 2,350 2,059
Patient-daysb 735 686 576
Medication daysc 1,688 1,489 1,331
Median length of hospital stay (days) 6.8 6.8 6.6
Mean of medication repeats (days)d 5.5 5.8 5.3
a Two included patients in period 2 and 8 in period 3 have been
admitted in the previous period but have stayed at the ward in the next
period
b The number of days that included patients received antibiotics or
anticonvulsants
c The number of days that included medications were continued for the
included patients
d The average number of days that an included medication of an
included patient was repeated
Table 3 Distribution of non-intercepted medication errors in the three periods
Error type Period 1,
n=1,688
Period 2,
n=1,489
Period 3,
n=1,331
P value,
period 1 and 2
P value,
period 2 and 3
P value
for trend
Prescription 876 (52%)a 749 (50%) 442 (33%) 0.4 <0.001 <0.001
Transcription 15 (1%) 16 (1%) 15 (1%) 0.6 0.9 0.5
Medication errorsb 891 (53%) 765 (51%) 457 (34%) 0.4 <0.001 <0.001
a Numbers in parentheses represent the percentages of crude numbers divided by n (n is the number of medication days in Table 2)
b A medication that contains both dose and frequency errors is considered as one medication-day error. Medication errors are the sum of
prescription and transcription errors
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In the neonatal ward and NICU, calculation of dose is
complicated and depends on several criteria [42, 43]. In
our study the high workload, tension, and stress of the
residents during their shifts resulted in a number of dose
calculation errors. Previous studies have shown that dose
calculation errors occur frequently among paediatric
residents [44, 45].
Another explanation of the high error rate is the methods
to detect medication errors [12]. Studies like Simpson et al.
[41] which are based on the critical or spontaneous reports
can detect only a fraction of medication errors [46]. Chart
reviews, especially when they are coupled with voluntary
reports like the study conducted by Kaushal et al. [5], can
detect a higher proportion of prescription errors. Direct
observation is appropriate for detecting administration
errors [46], though it is prone to biases like Hawthorne
effect [47]. The studies like Cordero et al. [20] that have
reviewed handwritten and electronic medical records have
detected a higher rate of medication errors. In sum, methods
are diverse and the results are difficult to compare. In our
investigation the researchers have reviewed both the hand
written and electronic medical records of orders and nursing
charts in all periods.
Period 2
The introduction of CPOE without CDSS functionalities
did not significantly reduce dose and frequency prescrip-
tion as well as transcription errors, which is inline with the
study conducted by Shulman et al. [48]. In that study,
following the implementation of a CPOE without DSS, the
rate of dose errors did not decrease and remained constant.
In their study, quick prescription and selection of drug
dosages from drop-down menus by prescribers was
mentioned as one of the factors contributing to medication
errors. However, that study was performed in a general
intensive care unit.
In our study, one probable reason that CPOE did not
reduce medication errors was that, in absence of a dosing
DSS, if we compare CPOE workflow with before CPOE
workflow (Fig. 3), we observe that CPOE has no specific
advantage to the before CPOE period in terms of prevent-
ing medication errors. Dose calculation in the neonatal
setting is complicated and prone to miscalculations [44,
45]. The amount of active substance in ampoules and vials
is usually appropriate for a single injection in adults.
Therefore, by using pre-constructed order sets with default
dose and frequency values and drop-down menus in a
computerized prescription system, it is probably possible to
reduce dosing errors in adults. However, in the neonatal
setting sometimes the appropriate dosage is less than one-
tenth of the pharmaceutical product. Therefore, in such a
context, the system should help the prescriber for individual
patients, and default values and drop-down menus are not
useful.
It can even be argued that since nurses were experienced
in typing, order entry by residents who had no previous
experience in data entry, and were under a high tension and
stress, should increase calculation as well as typing errors,
as the other studies addressed previously [15, 16, 48].
However, we had several training sessions for residents
before switching to physician order entry, and nurses
verified prescriptions and informed the residents in the
case of obvious typing mistakes. Therefore, physician order
entry in period 2 did not significantly worsen the error rate
of Period 1. Group and individual training sessions based
on the user level and physician–nurse collaboration are
mentioned as essential elements in successful implementa-
tion of CPOE [49–53].
Table 4 Distribution of non-intercepted dose and frequency errors in the three periods
Error type Period 1,
n=1,688
Period 2,
n=1,489
Period 3,
n=1,331
P value,
period 1 and 2
P value,
period 2 and 3
P value
for trend
Dose errorsa 690 (41%)b 559 (38%) 297 (22%) 0.06 <0.001 <0.001
Frequency errors 423 (25%) 377 (25%) 261 (20%) 0.9 <0.001 <0.001
a A medication error may contain both dose and frequency errors. Therefore, the sum of dose and frequency errors is higher than the total
medication errors.
b Numbers in parentheses represent the percentages of crude numbers divided by n (medication-days)
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One of the major advantages of a CPOE without DSS is
to prevent transcription errors by reducing frequent tran-
scriptions and paperwork between care providers. This has
been demonstrated in previous studies in the US and
Europe [48, 54]. However, in Iran the laws do not allow
withdrawal of paper-based orders. Therefore, even CPOE
cannot reduce transcriptions in this context [55]. Compar-
ison of the prescription workflow between CPOE and
before CPOE period reveals that transcription activities
(asterisks in Fig. 3) were not reduced after the introduction
of CPOE. Indeed, reduction of transcription errors requires
simplification of the prescription workflow and reduction of
paperwork. However, transcription errors had a small share
in the total number of errors in all three periods and
prescription errors contributed to most of the errors.
Kaushal et al. [5] have also mentioned that most of the
medication errors in the neonatal setting occur in the
prescribing stage.
Period 3
In our study, as in a number of previous studies, the
combination of physician order entry and a decision support
system in Period 3 resulted in a significant reduction of
medication errors [8, 9, 19, 20, 56]. The reduction pattern
shows that the rate of prescription errors was reduced but
the rate of transcription errors remained constant. This
strengthens the hypothesis that the rate of transcription
errors is mostly related to the complexity of the prescription
workflow and the number of transcription activities, not to
the DSS. Since the number of transcription activities was
not different in the three periods, the rate of transcription
errors remained constant over time. It seems that DSS is not
useful in reducing transcription errors, but is significantly
useful in reducing prescription errors. Since most of the
errors in the neonatal patients happen in the prescription
stage [5], this reduction highlights the value of introducing
CDSS in those neonatal wards that wish to improve their
quality of care but cannot increase the number of care
providers because of economic or other constraints.
Another pattern that could be observed is that in this
period, the dose errors were more often intercepted than the
frequency errors. One possible explanation is that miscalcu-
lations are always dose errors and it is easier to detect them by
a warning in comparison with other causes of errors.
Despite the significant reduction, medication errors were
not eliminated as they were in the study by Cordero et al. [20]
and Gard et al. [19]. Different reasons may account for such
a difference. Gard et al. used incident reports which can
underestimate the real number of errors. However, Cordero
et al. used a rigorous method, but they only assessed one
antibiotic (gentamicin). They also had a clinical pharmacist
who was actively involved in the intervention. In addition, in
their system, the initial dosages were suggested by the
system and not by the warnings. Therefore, they had
prevented the errors from the beginning.
The other reason is the role of ignored warnings. van der
Sijs et al. [23] have presented a list of previous studies
which demonstrate that between 22% and 90% of the dose
alerts were overridden. This may be due to several reasons
including alert fatigue, physician’s resistance, and inappro-
priate warnings. In addition, the complexity of appropriate
dose calculation among neonates [44, 45] increases the risk
of overridden warnings. In our study, when physicians
could not understand the reason of the alert, especially in
the complicated situations like renal insufficiency, they
would perceive the warning as being inappropriate and
ignored them. A warning without any explanation is
probably effective when an obvious mathematical calcula-
tion occurs. However, for the other causes of errors, the
method of calculation and the reason that the warning was
appeared should be demonstrated to increase physician’s
compliance.
When a warning only suggests a number as a correct dose,
and does not provide the rationale behind the calculation
method and the reason that the warning is appeared, it will be
difficult for the prescriber to guess how this number is
calculated and why this warning is appeared. One suggestion
is to add an explanation to the warnings based on the
investigated causes of errors. For example, the explanation
can inform the prescriber that the patient’s renal function is
impaired and dose should be reduced by a certain percentage
or frequency should be prolonged. Then the prescriber will
understand why the suggested dose or frequency does not
match with the original guideline. Otherwise, the prescriber
will ignore the warning, assuming that the DSS has suggested
a dose or frequency that is incorrect.
The frequency of alerts is another important problem. In
period 3, the alerts were only shown when a new dose was
set or one of the dose decision criteria was changed.
Therefore, if the resident ignored a correct alert, the
warning was not shown in the following orders and they
would remain erroneous. This could both increase medica-
tion errors and reduce the rate of error free patients. A
possible remedy is to design the system to provide alerts
more frequently, although this may increase users’ frustra-
tion and increase the risk of non-reviewed ignored warn-
ings, as stated by other studies [57].
Limitations
This study was performed in a neonatal setting, and therefore,
the results are not generalizable to adults. We selected the
same patient group over time because we could not divide
patients or prescribers into two groups and set a control group
34 J Med Syst (2011) 35:25–37
in the neonatal ward. CPOE implementation is a systemic
change that affects prescription flow in the ward.
We also could not form a control group from the other
wards of the hospital since the guidelines and measurement
methods for medication errors were different between the
neonatal and other wards.
Since medication errors in this study showed a linearly
decreasing trend from Period 1 to 3, and we did not have a
control group, it is possible that the errors were reduced not
only because of the warnings, but also due to the better
performance of prescribers. This can occur because the
residents were under a continuous training program. They
participated in different seminars and clinical rounds, and
accordingly their knowledge could improve over time.
Nevertheless, previous studies have reported that dose
calculation skill among paediatric residents is not related
to their experience, grade, level of training, or commitment
to recheck their calculated doses [44, 45].
It is also possible that prescribers improved their
performance in Period 3 because they knew that their
errors would be investigated, which might led to the
Hawthorne effect [47]. However, physicians knew from
the beginning of the study that their errors would be
investigated, and this general awareness was not limited to
Period 3. In addition, the additive design of the interven-
tions in our study reduces the impact of the Hawthorne
effect on the obtained results. However, the Hawthorne
effect should always be taken into consideration in the so-
called before and after intervention study designs.
The decision support system could assess only those
medications that were included in its knowledge-base, rather
than all medications that were prescribed and administered in
the neonatal ward. However, the calculation method is
generalizable to many other drugs that are prescribed with
the same dosing criteria in this ward. Exceptions could be
serums and IV electrolytes like sodium and potassium
chloride that are prescribed based on different criteria.
Conclusions
In the neonatal ward physician order entry without the
decision support functionality does not reduce non-
intercepted dose and frequency medication errors of anti-
biotics and anticonvulsants. However, when paired with a
dose decision support system, it is capable of reducing
these errors. The system is not effective in reducing
transcription errors in this context. It seems that the
reduction of transcription errors requires simplification of
the prescription workflow and restriction of the paperwork.
However, most of the errors occurred at the prescribing
stage where CDSS is quite effective. This effectiveness, to
some extent might compensate the lack of clinical pharma-
cists and other mechanisms required to recheck the
accuracy of the prescribed dosages in those hospitals that
they have serious human resource constraints.
When physicians do not understand the reasons of the
alerts, they may ignore them. Therefore, we suggest adding
explanations to the warnings which can describe to the
prescriber, how the system has calculated the appropriate
dose, and what is the reason that the warning is appeared.
Such an attempt may increase physicians’ compliance with
the system’s recommendations and further reduce medica-
tion errors.
Infrequent warnings increase the risk of repeated
medication errors. Using frequent warnings that appear in
every erroneous order may reduce this risk though it may
reduce physicians’ compliance.
Therefore, further studies are required to investigate the
compliance of physicians with the frequent warnings and
explanations and the effect of such a design on dosing
medication errors.
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